Catch CEO Dinesh Patel today live on Schwab Network around 1:35 ET!
schwabnetwork.com
#PTGX #SchwabNetwork #NextGenInvesting
Protagonist Therapeutics
@ProtagonistTx
Discovering and developing novel therapies through our proprietary peptide technology platform. #biotech #lifesciences #innovation
- Today, ICOTYDE™ was nominated for the 2026 #PrixGalien USA Award for Best Pharmaceutical Product. This recognition by @GalienFdn highlights the scientific innovation behind the first and only FDA-approved targeted oral peptide designed to block the IL-23 receptor, bringing a
- News: Protagonist Reports Second Quarter 2026 Financial Results and Provides Corporate Update Read more in our press release: tinyurl.com/5awxhatt
- The European Medicines Agency’s human medicines committee (CHMP) has adopted a positive opinion recommending ICOTYDE™ for marketing authorization in the European Union for adults and adolescents with moderate-to-severe plaque psoriasis. The EMA described ICOTYDE as the first
- 𝗪𝗲’𝗿𝗲 𝗛𝗶𝗿𝗶𝗻𝗴: 𝗣𝗿𝗼𝘁𝗮𝗴𝗼𝗻𝗶𝘀𝘁 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗶𝘀 𝘀𝗲𝗲𝗸𝗶𝗻𝗴 𝗮 𝗗𝗶𝗿𝗲𝗰𝘁𝗼𝗿, 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗮𝗹 𝗖𝗵𝗲𝗺𝗶𝘀𝘁𝗿𝘆 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻: Lead a medicinal chemistry team supporting small molecule and peptide drug discovery programs, driving
